ASX:MSBBiotechs
Mesoblast (ASX:MSB) Valuation Check As First R&D Day Puts Pipeline And Growth Plans In Focus
Mesoblast (ASX:MSB) is drawing fresh attention after announcing its inaugural R&D Day in New York City on April 8, 2026. At the event, leadership and external experts will outline corporate strategy and pipeline plans.
See our latest analysis for Mesoblast.
Those R&D Day plans come after a tough stretch for the share price, with a 30 day share price return of a 14.11% decline and a year to date share price return of a 25.27% decline, even though the three year total shareholder return is up...